Topic: ASCO 2011 Gastrointestinal Cancers Symposium abstracts

Intrahepatic cholangiocarcinoma: An international, multi-institutional analysis of prognostic factors and lymph node assessment.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=71397

Stereotactic body radiation therapy in the treatment of unresectable intrahepatic cholangiocarcinoma.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=71545

Role of histone deacetylase expression on regulating cancer stem cells in intrahepatic cholangiocarcinoma.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=70924

The role of mTOR and hypoxia pathway activation in promoting tumorigenesis of intrahepatic cholangiocarcinoma.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=70769

Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=71255

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: A phase II study of the Belgian Group of Digestive Oncology.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=70923

Treatment outcomes and prognostic factors for intrahepatic cholangiocarcinoma: Single-center experience.

http://www.asco.org/ASCOv2/Meetings/Abs … ctID=71559

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.